ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX), a biopharmaceutical company, is dedicated to in-licensing, developing and commercializing proprietary product candidates. Their key focus is on the treatment of cancer. The Company intends to enhance the performance and commercial potential of existing treatments by addressing issues related with these treatment regimens. For further information, visit the Company’s web site at www.adventrx.com.
- 17 years ago
QualityStocks
ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Advances The Dream Bowl With Tokenized Autographs, National ESPN+ Broadcast
Datavault AI (NASDAQ: DVLT) announced major advancements for The Dream Bowl, its all-star collegiate football showcase…
-
From Ghost Mines to Geophysical Clarity: How Fairchild Gold Corp. (TSX.V: FAIR) (OTCQB: FCHDF) Is Reframing Nevada Titan’s Copper-Gold Potential
Disseminated on behalf of Fairchild Gold Corp. (TSX.V: FAIR) (OTCQB: FCHDF) and may include paid…
-
GlobalTech Corp. (GLTK) Closes Acquisition of Moda in Pelle and Is Redefining Intelligent Retail with AI
GlobalTech Corp. announces that the company closed the acquisition of Moda in Pelle (“MIP”) to…